Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers

Japanese Journal of Clinical Oncology

Volumn 32, Issue 3, 2002, Pages 79-84

  Miyamoto, Kazuaki ^a,b   Fukutomi, Takashi ^c   Asada, Kiyoshi ^a   Wakazono, Kuniko ^a   Tsuda, Hitoshi ^a   Asahara, Toshimasa ^b   Sugimura, Takashi ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

BRCA1; Breast cancer; DNA methylation

Indexed keywords

BRCA1 PROTEIN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA EXTRACTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; METHYLATION; MUTATION; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; ADULT; AGED; BREAST TUMOR; DNA METHYLATION; FEMALE; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PROMOTER REGION; PROTEIN PROCESSING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA METHYLATION; FEMALE; GENE SILENCING; GENES, BRCA1; HUMANS; MIDDLE AGED; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER;

EID: 0036513696     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyf020     Document Type: Article

References (31)

1. Miki Y, Swensen J, Shattuck ED, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 1994;8:387-91.
3. Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, et al. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 1996;59:547-53.
4. Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, et al. The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet 1996;4:225-30.
5. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, et al. A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 1997;57:2474-7.
6. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 1995;57:1284-97.
7. Schubert EL, Mefford HC, Dann JL, Argonza RH, Hull J, King MC. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genet Test 1997;1:41-6.
8. Lalloo F, Cochrane S, Bulman B, Varley J, Elles R, Howell A, et al. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews. J Med Genet 1998;35:10-2.
9. Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M. Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 1995;55:3521-4.
10. Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, et al. Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum Mutat 1996;7:334-9.
11. Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 2001;91:83-8.
12. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
13. Cropp CS, Nevanlinna HA, Pyrhonen S, Stenman UH, Salmikangas P, Albertsen H, et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 1994;54:2548-51.
14. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 1995;9:444-50.
15. Kainu T, Kononen J, Johansson O, Olsson H, Borg A, Isola J. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res 1996;56:2912-5.
16. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature Genet 1999;21:236-40.
17. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 1999;5:1249-61.
18. Xu CF, Brown MA, Chambers JA, Griffiths B, Nicolai H, Solomon E. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 1995;4:2259-64.
19. Xu CF, Chambers JA, Solomon E. Complex regulation of the BRCA1 gene. J Biol Chem 1997;272:20994-7.
20. Dobrovic A, Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997;57:3347-50.
21. Magdinier F, Ribieras S, Lenoir GM, Frappart L, Dante R. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 1998;17:3169-76.
22. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, et al. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998;16:1161-9.
23. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-9.
24. Niwa Y, Oyama T, Nakajima T. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn J Cancer Res 2000;91:519-26.
25. Elston EW, Ellis IO. Method for grading breast cancer. J Clin Pathol 1993;46:189-90.
26. Sambrook J, Fritsch EF, Maniatis T. Isolation of high-molecular-weight DNA from mammalian cells. In: Sambrook J, Fritsch EF, Maniatis T, editors. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1989;9.14-9.23.
27. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827-31.
28. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-7.
29. Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M. Linkage analysis of BRCA1 in Japanese breast cancer families. Jpn J Cancer Res 1994;85:1233-9.
30. Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM. Regulation of BRCA1 by protein degradation. Oncogene 1999;18:6460-8.
31. Catteau A, Harris WH, Xu CF, Solomon E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999;18:1957-65.